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Abstract
Necrotizing enterocolitis (NEC) is an inflammatory disease of the newborn bowel, primarily affecting premature infants. Early intestinal colonization has been implicated in the pathogenesis of
NEC. The objective of this prospective case-control study was to evaluate differences in the intestinal microbiota between infants who developed NEC and unaffected controls prior to disease
onset. We conducted longitudinal analysis of the 16S rRNA genes of 312 samples obtained from
12 NEC cases and 26 age-matched controls with a median frequency of 7 samples per subject
and median sampling interval of 3 days. We found that the microbiome undergoes dynamic development during the first two months of life with day of life being the major factor contributing to
the colonization process. Depending on when the infant was diagnosed with NEC (i.e. early vs.
late onset), the pattern of microbial progression was different for cases and controls. The difference in the microbiota was most overt in early onset NEC cases and controls. In proximity to
NEC onset, the abundances of Clostridium sensu stricto from Clostridia class were significantly
higher in early onset NEC subjects comparing to controls. In late onset NEC, Escherichia/Shigella among Gammaproteobacteria, showed an increasing pattern prior to disease onset, and was
significantly higher in cases than controls six days before NEC onset. Cronobacter from Gammaproteobacteria was also significantly higher in late onset NEC cases than controls 1-3 days prior
to NEC onset. Thus, the specific infectious agent associated with NEC may vary by the age of infant at disease onset. We found that intravenously administered antibiotics may have an impact
on the microbial diversity present in fecal material. Longitudinal analysis at multiple time points
was an important strategy utilized in this study, allowing us to appreciate the dynamics of the premature infant intestinal microbiome while approaching NEC at various points.
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Introduction
Premature infants are disproportionally at risk for morbidity and mortality as a result of organs
that are immature and ill equipped for extrauterine life. These children are especially prone to
inflammatory disease as a result of a poorly-regulated immune system and an inappropriate inflammatory response[1–5]. Necrotizing enterocolitis (NEC), an inflammatory disease of the immature bowel that has been associated with aberrant intestinal colonization, represents the most
common cause of gastrointestinal (GI) morbidity and mortality among premature infants and is
a major contributor to poor growth and neurodevelopmental outcomes[6,7]. In spite of decades
of research, the prevalence of NEC among infants born between 500 and 1500 grams persists at
approximately 7 percent[8], and according to the National Institutes of Child Health and sHuman Development Neonatal Network, may range from 4 to 19 percent in infants born prior to
28 weeks of gestation[9]. In short, developing an improved understanding of the etiology of
NEC so that more effective prevention and treatment interventions may be developed is needed.
Prematurity and accompanying intestinal colonization are the only consistently identified
risk factors for NEC[6]. Thus, when prematurity cannot be prevented, intestinal colonization is
the major modifiable risk factor contributing to NEC. As a result, better understanding the pattern of intestinal colonization and community structure of the microbiome associated with
NEC is an important area of study in the etiology of the disease. The research conducted to
date on intestinal colonization and the microbiome aspects of NEC in premature infants using
non-culture based techniques has resulted in inconsistent findings. Some studies have been unable to demonstrate clear differences among cases and controls[10,11], while others have
shown that the community structure of the microbiome of the premature infant gut prior to
and at the time of disease onset is unique[12–16].
When evaluating differences in the microbiome at specific points in time, NEC cases appear
to first diverge from that of controls as early as three weeks prior to disease[12]. At two weeks
prior to disease, NEC cases have been shown to have an increased proportion of Proteobacteria
and a decreased proportion of Bacteriodetes when compared to controls[14]. At one week
prior to disease, the microbiome of cases and controls has also appeared differently[14,16];
however, these differences do not persist to within 72 hours of disease onset, which may be explained by the greater degree of heterogeneity in the microbiome under conditions of disease
when compared to the more stable and similar nature of the microbiome in control infants
[16]. Finally, at the time of diagnosis, NEC infants have been characterized by an overall lower
diversity index than the average premature infant[13].
While these studies have aided in our understanding of the disease, the prospective analyses
of NEC cases and healthy controls have reported on small sample sizes or at single time points,
not allowing us to see the more dynamic nature of the microbiome as the infant is both acquiring their intestinal microbiome and approaching disease. Thus, the objective of this prospective
case-control study was to measure differences in the intestinal microbiome over time at several
time points as measured in fecal material obtained from premature infants who developed
NEC and their unaffected controls.
By analyzing the 16S rRNA genes of 312 samples including 12 NEC cases and 26 controls,
we found that the microbiome undergoes dynamic development during the first two months of
life for both infants with NEC and their healthy controls. We also found that the pattern of microbial colonization was different for cases and controls in proximity to disease onset. The difference in the microbiome was most overt in cases of early onset NEC (< = 22 days at
diagnosis) and their controls.
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Methods
Ethics Statement
Samples were collected following a protocol that was approved by the Partner’s Human Research Committee (IRB) for Brigham and Women’s Hospital. All study procedures were approved by the IRBs at both Brigham and Women’s Hospital in Boston, MA and at The
Genome Institute in St. Louis, MO. The IRB deemed this study to be of minimal risk with no
interaction and no intervention with human subjects and thus, was exempt from consent.

Patients and samples
All infants were born at Brigham and Women’s Hospital in Boston, MA and cared for in a single-center Newborn Intensive Care Unit (NICU). Fecal samples were collected from preterm
infants born prior to 32 weeks of gestation from birth to discharge or 60 days of life, whichever
came first. We attempted to collect the stool samples in a daily basis, depending on when fecal
samples were available. Briefly, diapers with fecal samples were collected by the bedside nurse,
placed in a specimen bag, and stored at 4°C for no more than 24 hours. Samples were processed
daily, which involved extraction of fecal material from infant diapers using sterile procedures,
and immediately frozen at -80°C degrees until analyzed.
All infants were prospectively monitored for signs and symptoms of NEC. NEC was defined
as the presence of clinical criteria fulfilling modified Bell’s Stage II or III NEC[17], and as confirmed by the clinical team caring for the infant. Infants who met criteria for Spontaneous Intestinal Perforation (SIP) were excluded from this study[18].
All case infants (n = 12) were paired with two gestational age and temporally matched controls (n = 26). Two control infants were part of a twin pair and therefore, in two cases, three infants served as controls to one NEC case, resulting in 26 total controls. In addition to selecting
controls based on gestational age and temporal proximity to NEC cases, all controls were required to have multiple fecal samples that were collected at approximately (±2 days) the same
day of life as the matched case, thereby accounting for the potential influence of day of life on
the development of the microbiome. Comparison of demographics between case and control
groups were performed based on the data type as listed in Table 1.

DNA Extraction, sequencing, and sequence data processing
All samples included in the analysis (n = 312) were transferred to barcoded specimen tubes,
systematically placed in specimen boxes, packed in dry ice, and shipped to Washington University in St. Louis (WUSTL). These procedures prevented any samples from a thaw cycle during transit to WUSTL, where bacterial DNA was extracted from approximately 200 mg of fecal
material following the QIAgen QIAamp DNA Stool Minikit Protocol and using the QIAcube
(Qiagen, Germany). Isolated DNA was then transferred to The Genome Institute at WUSTL
for sequencing and analysis.
The V3–V5 region of the 16S rRNA gene was amplified using primers 357F (50 CCTACGGGAGGCAGCAG-30 ) and 926R (50 - CCGTCAATTCMTTTRAGT-30 ). Primers also
contained an adaptor sequence and one of 96 tags unique to each sample. PCR was performed
with the following conditions: 30 cycles of 95°C 2min; 50°C 0.5min and 72°C 5min. Amplicons
were purified, pooled at equimolar concentrations, and pyrosequenced on the Roche 454 Titanium platform using the protocol developed by Human Microbiome Project[19].
During the process of library preparation and sequencing, negative controls are included in
each pool and first checked by gel electrophoresis. Sequencing is conducted for negative controls that show no DNA contamination on the gel. This step ensures no strong contamination
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Table 1. Demographics of case and control groups.
Case (n =
12)

Control (n =
26)

Statistical test

pvalue

Adjusted pvalue

Gestational age (GA) (weeks of completed gestation at
birth)

27.8 (24–31)

27.9 (24–31)

t-test

0.84

1

Birth weight (BWT)

1048

1092

t-test

0.72

1

(940–1860)

(520–1800)

7 (58%)

14 (54%)

Chi-square test

1

1

Fisher’s exact test

0.71

1

C-Section

9 (75%)

17 (65%)

Vaginal Birth

3 (25%)

9 (35%)
Fisher’s exact test

0.003

0.04

White

3 (25%)

14 (54%)

Black

6 (50%)

10 (38%)

Other

3 (25%)

2 (8%)

(grams)
Sex (males)
Mode of delivery

Race

Apgar scores

Wilcoxon rank-sum
test

1

1-minute

5 (1–8)

6 (1–9)

5-minute

7 (4–9)

8 (2–9)

Maternal infection prior to birth

3 (25%)

5 (19%)

Fisher’s exact test

0.69

Maternal antibiotic exposure prior to birth

4 (33%)

6 (23%)

Chi-square test

0.69

1

Infant sepsis(culture positive)

3 (25%)

7 (27%)

Fisher’s exact test

1

1

Antibiotic exposure days prior to NEC

9 (4–33)

4.5(0–29)

Wilcoxonrank-sum test

0.06

0.78

Total enteral volume

1337

1963

0.09

1

fed prior to NEC

(5–3492)

(147–7165)

831

1456

0.09

1

(03352)

(0.6020)

Feeding History

NEC treatment
Medical

6 (50%)

Surgical

6 (50%)

Mortality associated with NEC

0.29
1

t-test

Total enteral volume of breast milk fed prior to
NEC

0.22

2 (17%)

NA

NA

NA

NA

NA

NA

NA

NA

Data are presented as means and ranges or number and percent. Maternal infections included chorioamnionitis. Infant sepsis was deﬁned as any culture
positive sepsis. Feeding history is described as the total enteral volume fed prior to time of NEC and the total enteral volume of breast milk fed prior to
time of NEC. Antibiotic exposure and feeding history data on controls is reported for the time period prior to day of NEC diagnosis in the matched case.
GA, BWt, Apgars, Antibiotic exposure days, feeding history = mean and range
Sex, mode of delivery, maternal infection & antibiotics, infant sepsis = number (%)
doi:10.1371/journal.pone.0118632.t001

coming from the environment. After sequencing, the number of reads from negative controls
is examined. If a large number of reads (>500 reads) is present in a negative control, the pool is
discarded and re-sequenced.
Data processing and quality control (QC) was performed according to standardized protocols developed by the Human Microbiome Project[19]. In brief, samples were binned by allowing one mismatch in the barcodes. Reads were filtered to remove those samples with average
quality score less than 35 and/or read length less than 200 nt. Chimeric sequences were removed using Chimera-Slayer [20]. Samples with less than 1000 reads were removed from the
analysis. Samples passing QC were then classified from phylum to genus level using the Ribosomal Database Project (RDP) Naive Bayesian Classifier (version 2.5, training set 9). Taxa
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assigned with less than 0.5 confidence were reassigned to the next higher taxonomic level in
which the classification threshold was greater than 0.5.

Exploratory and multivariate testing of bacterial community structure and
diversity
After initial sequence data processing, a taxonomical matrix was constructed with row as taxonomical classification and column as subjects. The taxonomical matrix was rarefied to the minimal number of reads in the matrix using the vegan package in R[21] before any further
analysis. We then used Nonmetric Multi-Dimensional Scaling (NMDS) to explore the microbiome data structure based on dissimilarity measurement (Bray-Curtis dissimilarity) between
two samples. NMDS is ordination technique. It aims to discover the data pattern in N dimensional spaces. For microbiome data, it allows the investigator to identify the subject relationships based on the bacterial compositions and abundances.
The different distribution of demographic factors in case and control groups were tested
based on data type as indicated in Table 1, and the P-values from multiple comparisons were
corrected using a Bonferroni approach. Permutational Multivariate Analysis of Variance (PERMANOVA) was used for formal statistical testing whether the bacterial community structure
differed between different variables. The relative abundances of the taxa were averaged for the
subjects with multiple time points when performing PERMANOVA. PERMANOVA partitions
the Bray-Curtis dissimilarity matrix among sources of variation, and used a permutation test
with pseudo-F ratios to obtain the p-values. To extract the genera that contribute to the difference between two bacterial communities, we performed Metastats analysis[22]. Metastats is a
statistical method based on Fisher’s exact test developed for the HMP study. The genera were
considered to be significantly different if (1) adjusted P value <0.05 using false discovery rate
approach, and (2) the mean relative abundance for a given genus was at least 1% in one group.
Univariables including richness and Shannon diversity were used to describe the bacterial complexity in a sample as previously reported[23]. Richness is defined as the number of different bacteria in a sample. Richness does not take the taxa abundances into account. Shannon diversity
quantifies both bacteria composition and their abundance, and it is a popular diversity index used
in ecology and human microbiome studies[23]. The diversity variation over time was modeled by
mixed linear regression using lmer4 in R [24]. Day of life, gender, and mode of delivery were entered into the model as fixed effects. Subjects in the model were used as random effects. P-values
were obtained by likelihood ratio tests of the full model against the model without the effect.

Results
Microbiome community structure in NEC cases and controls
We sequenced 312 stool samples from 38 individual subjects including 12 NEC cases and 26 controls with a median frequency of 7 samples per subject (IQR: 5–10) and minimal 1 sample per
subject. The median time interval of sample collection was 3 days (IQR: 1.3–5). The sample distribution in this dataset as a function of day of life was summarized in S1 Fig. The median day of life
of NEC onset for the 12 NEC subjects was 25.5 (IQR: 16.8–37.0). The significant differences in the
clinical characteristics of the cases and controls pertained to race and the number of days of antibiotics infants received prior to the time of NEC diagnosis (before P value adjustment) (Table 1).
In total, 2.6 million high quality and chimera free reads were produced. Fifteen phyla and
333 genera were detected in this data set, which included infants from birth to 60 days of age.
In general, zero to 50 reads are present in our negative controls. Because our study focused on
the relatively high abundant organisms as described in the materials and methods, and because
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we also rarefied the reads down to 1000 reads per sample, the reads in the negative controls
will have little impact on the results we have reported and the conclusion we have drawn.
Among all the taxa, Proteobacteria, Firmicutes and Actinobacteria were the three most
abundant phyla, accounting for 57.4%, 41.2% and 1.0% of the total reads. Clostridium sensu
stricto, representative of a genus in cluster I in Clostridium phylogeny[25], was the most abundant genus in this dataset. It was present in 64.4% of the samples, and accounted for 21% of the
total reads in this dataset. The most prevalent genus was Enterobacter, present in 95% of the
samples, indicating that this bacterium is likely to represent the longitudinal core genera during
the early days of life (0–60 days) in premature infants. Other highly prevalent genera were
Staphylococcus and Escherichia/Shigella, were also present in more than 80% of the samples.
During early life, when the intestinal microbiome is first established, the microbes populating the gut are undergoing dynamic succession and multiple factors potentially contribute to
this developmental process. To understand this developmental process, we examined how different factors affect the bacterial community structure. Bacterial community structure refers to
the bacterial compositions and abundances in one sample or a group of samples. As shown in
the NMDS plot, the day of life is the most striking driver of the development of the gut microbiota among these premature infants(Fig. 1, S2 Fig.), and this age dependent cluster pattern
was especially evident in the samples analyzed at the genus level. Samples were not clustered by
antibiotic usages and health status (NEC and healthy control) (S3 Fig.).
To examine the difference in the bacterial community between NEC and healthy controls at
the day of NEC diagnosis, we illustrated the differences in the bacterial community of NEC subjects and their controls by NMDS plot. Six of the twelve NEC cases in this study had samples
available for analysis at the time of disease onset. No clear separation was observed between
NEC cases and the controls (S4A, C Fig.); PERMANOVA testing showed no statistically significant differences between NEC and controls at day of NEC onset (p = 0.52 for genus level and p
= 0.40 at class level). Instead, at the genus level, the six NEC samples were segregated in the first
dimension of the NMDS plot, with the three NEC samples from onset day 23 to 35 on the left
side and the three NEC samples from onset day of life (DOL) 10–22 on the right side of the first
dimension (S4C Fig.). Barplots of the top five abundant classes demonstrated that three NEC
subjects (1, 2 and 3 DOL< = 22) were dominated by Clostridia with the relative abundances of
50.0%, 94.8% and 29.7%, respectively, while the other three NEC(4, 5,6) were dominated by
Gammaproteobacteria with the relative abundances of 73.4%, 98.8% and 46.2%, respectively
(S4B Fig.). At the genus level, three (NEC 1, 2 and 3 DOL< = 22) out of six NEC subjects were
dominated by Clostridium sensu stricto from Clostridia class, while the NEC samples 4,5,6 with
high abundance Gammaproteobacteria class were heterogeneous, with Pseudomonas, Pasteurella, Serratia and Klebsiella being the most prevalent genera, respectively (S4D Fig.).
The finding that the microbial community on the day of NEC onset did not cluster by disease is
perhaps not surprising given the range in the day of life that NEC was diagnosed among these
cases (day 10–35) and the strong influence of day of life on the gut microbiota as indicated above.
To minimize the effect of day of life on the microbiome when comparing the NEC cases and their
controls, we separated the NEC subjects into two groups: (1) early onset disease (day of NEC onset
< = 22) and (2) late onset disease (day of NEC onset >22). In the absence of any consensus regarding cutoffs for early versus late onset NEC, we chose this interval after inspecting pilot NMDS data
from samples obtained on the day NEC was diagnosed (S4C Fig.), as described above.
Based on the data available, the disease course was analyzed and NMDS was performed at
the second and third week of life for the early onset NEC group, and from the second to sixth
week of life for the late onset group. In these analyses, only data prior to or on the day of disease
were included, ensuring that the findings at these time points represent the microbiome prior
to the time of NEC diagnosis. Interestingly, we observed a clear separation of early onset NEC

PLOS ONE | DOI:10.1371/journal.pone.0118632 March 5, 2015

6 / 16

Premature Infant Intestinal Microbiome and Necrotizing Enterocolitis

Fig 1. Premature gut microbiota variation in the first two month of life. The gut microbiota variation at class level over 0–60 days of life from all the
samples is visualized by NMDS plot. The color gradient from red to blue represents the day of life of the babies. The microbiota from early day of life is
distinguished from the elder days.
doi:10.1371/journal.pone.0118632.g001

and controls at the second week of life at the genus levels (p = 0.01) (Fig. 2A, S1 Table), suggesting that the microbiota were different between early onset NEC samples and control. However,
no significant difference was found between early onset NEC and controls at the third week of
life (p = 0.36).
In NEC subjects, at the class level the median relative abundance of Clostridia was 56.4% at
second week of life, but decreased to 29.7 at third weeks of life (S5B Fig., p = 0.02). However, in
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controls, Clostridia increased from 0.1% to 3.8% over the same time points. The median relative abundances of Gammaproteobacteria were 21.9 and 92.0% in NEC and control groups at
second week of life, but then showed different trend patterns as they reached approximately
63.0% for both NEC and control at third week of life. At the same time points, the median relative abundance of Negativicutes showed minor changes in NEC and controls with no statistical
significance (S5B Fig.). At the genus level, Clostridium sensu stricto was seven times more abundant in NEC cases than in controls at second week of life, and decreased significantly after one
week in NEC (p = 0.05) but increased in controls although no significant difference was found
(p = 0.22). Pasteurella was the only high abundant genus (22.7%) that increased in NEC samples at second week of life (p = 0.007). Pasteurella was not detected in controls (S5C Fig.).
In the late onset NEC group, the separation among cases and controls is not as evident as
the early onset NEC cases and their controls (Fig. 2B), with only the first three weeks showing
marginal significance (p = 0.06, p = 0.05, p = 0.05, respectively) at genus level (S1 Table). The
NEC subjects were also distinct from each other, and the individualized distribution became
more notable with increasing age, especially at six weeks of life. The latter observation was in
line with the NMDS portrayal at day of NEC (S4 Fig.). While we have reported significant p
values in all of the above analysis, these should be interpreted with caution given the small sample sizes included in both the early and late onset analyses.

Progression of microbiota prior to NEC onset
To characterize the differences in intestinal colonization between NEC cases and controls prior
to disease onset, we compared the community structure of the microbiome in cases and controls from 7–9 days, 4–6 days, and 1–3 days prior to early onset and late onset disease. In analyzing the data in this manner, we found that prior to early onset NEC, four classes of bacteria
showed interesting patterns in the microbiome 9 days prior to disease (Fig. 3A): (1) The
amount of Gammaproteobacteria in controls maintained the same predominance for 9 days
before NEC onset, yet it is significantly higher in controls than in NEC samples at 7–9 and 4–6
days prior to NEC onset (p = 0.01 and 0.008, respectively), and not significantly different just
before disease onset as a result of Gammaproteobacteria from NEC cases showing an increasing trend while approaching disease. As seen in Fig. 3A, 1–3 days before NEC onset, Gammaproteobacteria in cases reached a similar level as the controls. Klebsiella is the major genus
from Gammaproteobacteria in the early onset group, however, its relative abundance was not
significantly different between NEC and controls. Escherichia/Shigella was significantly higher
in controls than early NEC cases (p = 0.005) (2) Strikingly, bacteria from the Clostridia class
(Clostridium sensu stricto as the major genus) in the NEC samples was found to be significantly
higher than in the controls consistently from 1–9 days before NEC onset (p = 0.01,0.05 and
0.01 for 7–9, 4–6, 1–3 days before onset) (3) Bacilli (especially Staphylococcus genus) decreased
within the 9 days of disease in the early onset NEC cases, while no obvious changes were detected in controls samples. (4) Negativicutes were low in abundance and we did not find any
significant changes for bacteria in this class among the early onset group.
In analyzing the late onset group, we also found four interesting trends in the microbiome
of premature infants with NEC as compared to their controls. (1) Gammaproteobacteria
showed a steady decreasing trend in controls and increasing trend in NEC samples (Fig. 3B).
The Gammaproteobacteria became significantly higher 1–3 days prior to the late onset NEC
(p = 0.03). Genus level analysis demonstrated that not all of the genera from Gammaproteobacteria showed an increasing trend in NEC samples. Escherichia/Shigella indicated a drastic
increase, as they became significantly higher than controls 1–3 days and 4–6 days prior to NEC
(p = 0.02). Klebsiella and Enterobacter decreased towards diseases onset and Enterobacter
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Fig 2. NMDS of early and late onset NEC and controls at the genus level. The difference between NEC and controls is displayed for early onset NEC
(Fig. 2A) and late onset NEC (Fig. 2B) with their controls by NMDS plot. Each dot represents one sample. Green dots represent the controls and red dots
represent the NEC samples. Early NEC subjects and control subjects have a clear separation at second week of the life. The distinction between late onset
NEC and controls is less obvious except at the third week of life.
doi:10.1371/journal.pone.0118632.g002

became significantly lower in the 1–3 days prior to NEC. (2) The abundance of Bacilli (mainly
Enterococcus) showed no significant difference between cases and controls, and their abundance did not show significant variation over the 9 days prior to late onset NEC (p>0.05).
(3) In contrast to early onset NEC, Clostridia (mainly Clostridium sensu stricto) decreased or
maintained a low abundance at the class level in samples representing NEC cases, while the
control subjects demonstrated a microbial trajectory characterized by an increasing proportion
of Clostridia within 9 days before disease. The abundances of Clostridia were not significantly
different between case and controls at the three time points (p>0.05) (4) Negativicutes increased in the late onset control subjects while no obvious change was detected in the late onset
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Fig 3. Microbiota progression before early onset NEC and late onset NEC at class and genus level. The relative abundances of four most dominant
classes (Fig. 3A-early onset at class level, 3B-late onset at class level) and the genera (Fig. 3C-early onset at genus level, 3D-late onset at genus level) that
are significantly different between NEC and controls are plotted at 7–9 days, 4–6 days and 1–3 days prior to NEC onset. In early onset NEC category, 3,6, 8
NEC samples were included at 7–9 days, 4–6 days and 1–3 days; 8, 5, 6 control samples were included in the above time points. In late onset NEC category,
7, 7,10 NEC samples and 6, 8, 4 control samples were included in the above time points. Red and green of the boxplots indicate NEC and control samples,
respectively. The asterisks indicate the significant difference between NEC and control.
doi:10.1371/journal.pone.0118632.g003

NEC subjects. However, at the genus level, we found Veillonella was significantly higher in controls than NEC cases 1–3 days prior to NEC onset (p = 0.005).

Microbial diversity in NEC cases and their controls
Previous prospective case-control studies have reported inconsistent findings on the microbial
diversity associated NEC [10,12,14–16]. We used mixed linear regression to assess the effect of
different variables including, day of life, mode of delivery, gestational age, and gender, on the
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microbial complexity among samples in this study. The microbial complexity measured by
richness and Shannon diversity describes the number of different taxa and their abundances in
a sample, respectively. The goal of using mixed linear regression on the microbial diversity is to
evaluate the difference in diversity variation between comparison groups over time. In this
study, we analyzed the diversity at the genus level, given the more complex bacterial community at a lower taxonomical level. Richness and Shannon diversity from the samples before NEC
onset increased significantly over the 2 months of life (p = 9.76E-14 for Shannon diversity, and
p = 0.003 for richness), indicating day of life is a critical factor affecting the complexity of the
bacterial community.
The control samples have significantly higher richness (p = 0.03) but not Shannon diversity
overtime, suggesting that the pace of colonization in NEC subjects is slower than their matched
controls. Mode of delivery, gestational age, and gender showed no significant influence on the
diversity measured (p>0.05).
In this analysis, antibiotic usage was not included in the NEC model because of the complexity in determining the influence of this variable on the outcome of the microbiome at a specific
point in time. For example, the type, dosage, and duration of antibiotic usage may all have an effect on the intestinal microbiota. In this study, the infants received broad spectrum intravenously (IV) administered antibiotics (not oral antibiotics) following birth, which is a routine practice
common to preterm infants in the NICU. While recent findings have shown that there is a disturbance in the gut microbiota associted with IV antibiotic therapy in adults[26], the molecular
mechanisms require further study and whether or not this same influence is observed in preterm infants early in life is unknown.. Here, we performed an initial investigation relative to this
issue by comparing the microbial diversity between healthy subjects who received antibiotics
within 5 days of sample collection and subjects who did not have antibiotic usage at least five
days before sample collection. We chose only the control subjects to exclude the potential effect
of disease itself on diversity. The selected samples were obtained between days of life 7 to 14.
The comparison was done after adjusting day of life, gender, feeding, mode of delivery and presence of maternal infection. The diversity including richness and Shannon diversity were lower
in subjects treated by antibiotics within five days vs subjects who did not (S6 Fig.), with a marginally significant difference on richness (p = 0.09 for richness and 0.18 for Shannon diversity),
suggesting IV antibiotic treatment may influence the complexity of the premature infant intestinal microbiome. As described above, NEC samples tended to have lower microbial diversity
than controls, and they also have marginally more antibiotics usage than controls (Table 1 before p value correction). We speculate that the low diversity in NEC samples may be due in part
to the increased exposure to antibiotics outside the treatment for NEC among these infants.

Discussion
In our study, which consists of a larger cohort of premature infants and a greater number of
samples at more frequent time points prior to disease than have been reported in other studies,
we identified specific patterns of altered microbial composition prior to NEC that are unique
based on when NEC was diagnosed in the infant’s life. The time dependent variation in the
microbiome is not surprising because the infants’ intestinal microbiota is under rapid development in early life and the microbiome has been shown to be highly dynamic until approximately
two years of age [27]. As seen in our results, the changing microbiota was largely affected by day
of life and less by other clinical variables, which suggests that the microbiome comparison between NEC cases and their controls should be confined to a similar time frame following birth.
The day of NEC onset in our study spanned from day 9 to 55. This wide range in age at the
time of disease is a confounder in the microbiome comparison between NEC cases and controls.
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This is evident from our NMDS plot using all of the NEC onset data in which early and late
onset NEC samples were distinct. To deal with the influence of day of life on the microbiome
community structure, we divided the NEC samples into early and late onset groups and compared the colonization pattern of the microbiome with their matching controls. We observed a
clear separation of early onset NEC samples with their controls. However, this separation is less
clear for late onset NEC samples and controls. In the latter case, the microbiome appears to
have a more individualized pattern. The high inter-subject variation in late onset NEC and their
controls is consistent with previous study on the process of intestinal bacterial colonization
early in life [28, 29]. Previous studies showed NEC cases and controls were segregated, suggesting their microbiomes were different [12,14,16]. However, these studies are based on single sampling points or smaller sample size, considering the high inter-subject variation, future studies
that involve larger sample sizes and cross-center data comparisons will have the ability to further explore the inter-subject variation that has currently been identified with greater accuracy.
Is there a common pathogen attributable to NEC? The pathogen that has been most commonly associated with NEC, Cronobacter sakazakii, has demonstrated that virulence is not a
property of a bacterial species as a whole [30–33]. Rather, pathogenicity may be a function of
the host response to the characteristics of specific strains within a certain species of taxa [30] In
addition to Cronobacter, earlier studies using culture based techniques and recent studies using
metagenomic approaches have linked several bacteria to NEC. These bacteria have primarily
been identified as Gram-negative species (i.e. Klebsiella pneumoniae) [10,12,14,15,34,35]. However, there have also been observations suggesting that Gram-positive bacteria (i.e. Enterococcus
faecalis) [36] and anaerobic species (i.e. Clostridium) may contribute to the etiology of NEC
[37]. Our study investigating NEC using a metagenomic approach demonstrated an imbalanced
bacterial community in NEC. By analyzing the data 9 days prior to NEC onset, we found a
higher abundance of Clostridium sensu stricto (genus) from Clostridia (class) in early onset
NEC samples when compared to their controls. This observation did not hold true in late onset
NEC cases, where Escherichia/Shigella were higher. The inconsistent finding between early and
late onset NEC may have resulted from the age difference of the infants at the time of disease, as
the bacteria associated with NEC are influenced by the natural colonization process over time
in these infants. Taken together, these findings suggest that a common specific pathogen associated with all NEC is lacking. This is not surprising, given that in the molecular and high
throughput sequencing era of microbiology, where multiple PCR and metagenomic sequencing
of biological specimens have the potential to discover numerous organisms or pathogens, the
concept of one pathogen resulting in one disease is currently being challenged. Experimental
animal model based validation is warranted to identify the real causative agents.
Longitudinal analysis at multiple time points has allowed us to recognize the dynamics of
the microbiome while approaching disease. Focusing on the early onset NEC samples, we can
see that it is not an absolute change in abundance of a specific bacteria that is most relevant
when studying the microbiome in proximity to disease. Rather, it is the trend among the members of the microbiome over time that seems to be associated with disposition for disease. The
abundance of Gammaproteobacteria in early onset NEC provides an important example of
trending microbiome data. As seen in Fig. 3A, if we evaluate the differences in Gammaproteobacteria at discrete time points prior to NEC, we would likely conclude that Gammaproteobacteria is overwhelming protective against NEC (i.e. higher Gammaproteobacteria observed in
controls at all of the time intervals before disease). However, the trend data as observed over
the nine days preceding NEC shows that while NEC cases do indeed have a lower abundance
of Gammaproteobacteria than controls, this abundance dramatically changes as the infant approaches disease. Therefore, NEC may evolve as a result of an increasing abundance of Gammaproteobacteria as the infant approaches disease. This changing trend is in stark contrast to
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the relatively unchanging abundance observed in controls at the same time points, suggesting
that the change may be contributing as much to the etiology of the disease as the community
structure of the microbiome.
While the overall community structure and balance between pathogenic and commensal
bacteria within the intestinal microbiome is very likely to influence the development of NEC,
to what extent the microbiome drives the etiology of NEC is not clear. As in many other diseases, where the disease evolves as a result of the interaction between the pathogen and the
host, we think that there is a greater need to understand the premature infant inflammatory response to intestinal bacteria, as this response is likely playing a significant role in the etiology
of NEC. This area of inquiry is especially important given recent findings, which have shown
that the immune system of the infant born at term is “turned-down” for a period of time early
in life, presumably to allow for the rapid intestinal colonization that occurs following birth
[38]. How the immature immune system is programmed to facilitate early intestinal colonization of the premature infant is unknown. Future research on the immature immune response,
in tandem with early intestinal colonization, may help develop interventions that attenuate the
inappropriate inflammatory response that characterizes NEC in premature infants.
Future work on the preterm infant intestinal microbiome and NEC will require an in depth
exploration of the influence of clinical variables such as mode of birth, antibiotic exposures, and
nutrition [39]. Of these, nutrition is likely to be a significant contributor to the development of
the microbiome and its role in the pathogenesis of diseases such as NEC. For example, studies
have shown a protective effect of breast milk against NEC [40] due to the bifidogenic nature of
breast milk. In addition, studies have shown that the intestinal microbiome is strongly influenced
by diet during infancy [29,41,42]. Further analysis of the influence of nutrition on the microbiome and in association with NEC was outside the scope of the current study design as the infants included in this study were fed a mix of human milk and infant formula. Future study
designs that have the ability to investigate groups of infants who are fed a diet that is exclusive
for human milk or infant formula will be best positioned to explore the influence of nutritional
exposures on the acquisition and development of the preterm infant intestinal microbiome.
In summary, there are discernible and potentially meaningful trends in the microbiome
over time in premature infants who developed NEC. While this is the largest such study reported to date, its major limitation remains a small sample size. Fluctuations in microbial content in this interval in life, and the nearly 7 week interval of life over which NEC occurred,
further reduce our ability to compare cases and controls. Therefore, we recommend that caution should be taken in the calculation and interpretation of the statistics applied to the study.
Future studies with larger sample sizes are needed to more fully describe the differences in the
premature infant intestinal microbiome associated with NEC.

Supporting Information
S1 Fig. Sample frequency and time Interval of sampling. X-axis represents individual subject.
Y-axis represents the day of life that a given sample is collected.
(TIF)
S2 Fig. Premature gut microbiota variation in the first two month of life at the genus level.
The gut microbiota variation at genus level over 0–60 days of life from all the samples is visualized by NMDS plot. The color gradient from red to blue represents the day of life of the babies.
(TIF)
S3 Fig. Microbiota from all the samples are not separated by case and controls as well as by
the antibiotic usage. (A) NMDS plot at class level. Samples are colored by NEC or control
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groups (B) NMDS plot at genus level. Samples are colored by NEC or control groups (C)
NMDS plot at class level. Samples are colored by the accumulated antibiotic usages. We assigned 1 for antibiotic usage and 0 without antibiotic usage. If multiple antibiotics were used at
a given day, we summed up antibiotics to indicate the total antibiotic usage for the day. The
color gradient shows the accumulated antibiotic usages overtime.
(TIF)
S4 Fig. No difference between NEC and control at the day of NEC. (A) NMDS plot of microbiota in NEC and controls at the class level at the day of NEC (B) The relative abundances of
top five microbiota in 6 NEC samples (top) and their corresponding control samples (bottom)
at class level. The NEC subjects are labeled as 1–6. 1–3: the early onset subjects; 4–6: the late
onset subjects. Their corresponding control samples have the same label as the NEC cases. (C)
NMDS plot of microbiota in NEC and controls at the genus level at the day of NEC diagnosis
(D) The relative abundances of top 25 microbiota in 6 NEC samples (top) and their corresponding control samples (bottom) at genus level. The samples are labeled exactly as (B). The
color scheme for each of the five taxonomical classes in S4B Fig. matches at least one of the
color for the taxa within the same class.
(TIF)
S5 Fig. Microbiota comparison between early NEC and controls at the class level. Each dot
represents one sample.. All the control samples are coded by green, and all the NEC samples were
colored with red in the NMDS plots (A1 and A2). The relative abundances of the four bacterial
classes at the second and third week of life for NEC and controls samples (B). The relative abundances of two bacteria genera that are significantly different between second and third week (C).
(TIF)
S6 Fig. Low diversity in antibiotic usage control samples. Richness (A) and Shannon diversity (B) are shown for samples treated with antibiotics within five days and samples without antibiotics for at least five days. The samples are from NEC control group from second week of
the life.
(TIF)
S1 Table. PERMANOVA analysis of the early onset NEC and controls.
(DOCX)
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